Gibberellic acid (GA 3 ) phytohormone responsible for bakanae disease development is 22 well-known and identified. But a number of secondary metabolites along with GA 3 , produced by 23 the causal pathogen in relation to bakanae symptoms expression were unknown. Therefore, the 24 aims of this research were to evaluate the symptoms expression analysis of bakanae disease by 25 pre-seed treatment with pure (synthetic) phytohormones and metabolites in susceptible rice 26 variety MR 211. The typical bakanae symptoms were evaluated by applying pure GA 3 , FA and 27 MON either singly or in mixtures. It was confirmed that higher concentration of GA 3 singly or 28 with higher concentration of GA 3 and MON in mixtures, caused unusual elongation of 29 internodes. Plants became stunted when high concentration of FA was applied. Browning of 30 leaves and stems, crown rot, root necrosis occurred and root length was decreased when mixtures 31 of higher concentration of FA *MON*GA 3 were used as pre-treatment. Similar observations 32 were noted in plants inoculated with F. proliferatum at different score levels. The mechanisms of 2 33 bakanae disease development through different symptoms expression in susceptible variety 34 infected with F. proliferatum were identified. 35 36 Introduction 37 Fusarium fujikuroi, causal agent of bakanae disease is known to produce gibberellic acid 38 (GA 3 ), fumonisin (FB1), monilifornin (MON), fusaric acid (FA) and beauvericin (BEA) in 39 diseased plant [1-4]. GA 3 is a growth promoting phytohormone but abnormal production of GA 3 40 has been identified as a break-through in disease development and disease resistance or 41 susceptibility in plants [5]. In addition, GA 3 has been identified as being responsible for increase 42 in plant height, whereas FA is responsible for decrease in plant height. Fungal metabolites MON, 43 FB1 and BEA have been identified for causing phytotoxicity in plants rather than establishment 44 of pathogenicity or disease symptoms expression in bakanae diseased plants [1, 6-7]. Besides 45 Fusarium fujikuroi, Fusarium proliferatum is also identified as a causal agent of bakanae disease 46 [8] and GA 3, FB1, MON, FA were also isolated from bakanae diseased plants infected with F. 47 proliferatum [ 9]. It was also assumed that GA 3, MON and FA had strong influence on bakanae 48 symptoms expression as a significant amounts of GA 3, MON and FA were isolated from the 49 infected susceptible variety (data not presented here). Therefore, this study was carried out to 50 verify the role of GA 3 , MON and FA on bakanae symptoms expression, following exogenous 51 pre-treatment on seeds of susceptible variety MR 211 instead of inoculation with F. proliferatum 52 over time.
After the single pre-treatment trial, mixtures with two pre-treatment combinations and mixtures 90 with three pre-treatment combinations were employed to observe the symptoms expression in 91 mixtures with different treatment combinations. All procedures used were the same as in the 92 single pre-treatment trial. Development of symptoms associated with the pre-treatments, either 93 singly or in mixtures with two and three pre-treatment combinations was recorded weekly for 3 94 weeks.
96
Sampling procedure and data collection 97 Plants were uprooted carefully without damaging the root tissues at the different 98 sampling times. Sampling times were determined based on disease score levels as follows: level 99 1 (7 days after pre-treatment), level 3 (14 days after pre-treatment) and level 5 (21 days after 100 pre-treatment). The stems, leaves (uppermost second leaf) and roots were separated, and stem 101 and leaf lengths were measured using a measuring scale (1 m). 
Effects of pre-treatment with GA 3, FA, and MON on stem cell elongation (Histopathological

Analysis of symptoms expression in plants pre-treated with pure GA 3, FA and MON applied
122 singly or in mixtures 123 124 Symptoms expression were analysed in plants pre-treated with pure GA 3, FA, and MON 125 at two concentrations applied singly and in mixtures with two and three treatment combinations 126 at stipulated disease scoring levels (score 1, 3 and 5) on percent increase or decrease basis in 127 comparison with diseased control plants. Data were analysed using SAS software (Version 9.2). 132 133 Both GA 3 concentrations increased stem height, whereas the other pre-treatments 134 decreased stem height after 7 days of pre-treatment. Highest stem height decrease was observed 135 in pre-treatment FA (400 mg/L) after 7 days of pre-treatment. It was also observed that the 136 increasing trend in stem height in GA 3 pre-treatment declined after 7 days to after 21 days. In 137 contrast, pre-treatment with MON (120 µg/L) showed increasing stem height after 14 days of 138 pre-treatment and was found to continue increasing after 21 days which was similar to pre- In contrast, pre-treatment with FA showed stunting in stem height, which may be due to the 155 shorter stem cell length. This percentage decrease in stem height observed was probably due to 156 the higher cell division that occurred in plants at disease score 1, which caused shorter cell The highest decrease in root length was observed after 7 days, while it was found to increase 208 after 14 days in all pre-treatments along with the diseased control. The highest decrease in root 209 length was observed in pre-treatment with GA 3 (15 mg/L) followed by the diseased control and In contrast, plant height stunting was found to be mainly due to the effect of FA rather than GA 3 . 
Results
131
Effects of GA 3 , FA and MON applied singly
